Wealth Enhancement Advisory Services’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$296K Buy
4,590
+439
+11% +$32.2K ﹤0.01% 3359
2026
Q2
$313K Sell
4,151
-184
-4% -$14.1K ﹤0.01% 3163
2026
Q1
$360K Sell
4,335
-348
-7% -$29K ﹤0.01% 2606
2025
Q4
$358K Buy
4,683
+400
+9% +$30.7K ﹤0.01% 2765
2025
Q3
$324K Buy
4,283
+274
+7% +$20.5K ﹤0.01% 2721
2025
Q2
$284K Buy
4,009
+398
+11% +$29.2K ﹤0.01% 2689
2025
Q1
$267K Buy
3,611
+357
+11% +$25.2K ﹤0.01% 2538
2024
Q4
$226K Buy
+3,254
New +$247K ﹤0.01% 2612
2024
Q3
– Sell
-3,094
Closed -$210K – 2882
2024
Q2
$210K Buy
+3,094
New +$198K ﹤0.01% 2266

Other funds holding NHI

Wealth Enhancement Advisory Services's NHI Position: Q3 2026 in Review

Wealth Enhancement Advisory Services increased its National Health Investors (NHI) stake by 11% in Q3 2026, buying an estimated $32.2K and bringing the position to 4,590 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #3359.

Wealth Enhancement Advisory Services first reported a position in NHI in Q2 2024 and has held it in 9 quarters since. The position peaked at $360K in Q1 2026. 16 funds tracked by Wall St. Rank hold NHI as of Q3 2026.

  • Wealth Enhancement Advisory Services held 4,590 shares of National Health Investors worth $296K as of Q3 2026.
  • Wealth Enhancement Advisory Services bought 439 National Health Investors shares in Q3 2026, an estimated $32.2K.
  • National Health Investors made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3359 holding.
  • Wealth Enhancement Advisory Services first reported a position in National Health Investors in Q2 2024 and has held it in 9 quarters since.
  • Wealth Enhancement Advisory Services's National Health Investors position peaked at $360K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held National Health Investors as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.